Zalman life science
Loading..
Loading..
Showing 331–360 of 596 results
Cortiband-100 is a sterile injectable preparation containing hydrocortisone sodium succinate, a fast-acting glucocorticoid. It is used in the management of severe allergic reactions, anaphylaxis, asthma, adrenal insufficiency, rheumatoid arthritis, severe dermatological conditions, and shock due to trauma, burns, or infections. Hydrocortisone provides anti-inflammatory and immunosuppressive effects, helping to control acute and life-threatening conditions.
Cefband-SB 1.5 gm is a sterile injectable antibiotic combining ceftriaxone, a third-generation cephalosporin with broad-spectrum bactericidal activity, and sulbactam, a β-lactamase inhibitor that prevents enzymatic degradation of ceftriaxone by resistant bacteria. This enhances the effectiveness of the treatment. It is indicated in moderate to severe infections such as respiratory tract infections, urinary tract infections, intra-abdominal infections, septicemia, meningitis, skin and soft tissue infections, and bone and joint infections.
Cefband-SB 750 is a sterile injectable combination of ceftriaxone, a third-generation cephalosporin with broad-spectrum bactericidal activity, and sulbactam, a β-lactamase inhibitor that enhances ceftriaxone’s effectiveness against resistant organisms. It is used for the treatment of moderate to severe bacterial infections including respiratory tract infections, urinary tract infections, intra-abdominal infections, septicemia, skin and soft tissue infections, bone and joint infections, and meningitis.
Centocef-1.5gm is a sterile injectable antibiotic that combines ceftriaxone, a third-generation cephalosporin with broad-spectrum bactericidal activity, and sulbactam, a β-lactamase inhibitor. This combination enhances the efficacy of ceftriaxone against resistant bacteria. It is indicated for the treatment of severe bacterial infections such as respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, bone and joint infections, septicemia, and meningitis. It is also used in surgical prophylaxis.
Centocef-1gm is a sterile injectable formulation containing ceftriaxone, a third-generation cephalosporin antibiotic with broad-spectrum activity against gram-positive and gram-negative bacteria. It is indicated for the treatment of severe bacterial infections such as respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, bone and joint infections, septicemia, and meningitis.
Betazal – 4 ml is an injectable corticosteroid preparation containing betamethasone, a potent glucocorticoid with strong anti-inflammatory and immunosuppressive properties. It is used in the treatment of severe allergic reactions, asthma, rheumatoid arthritis, dermatological conditions, endocrine disorders, and other inflammatory or autoimmune diseases. It may also be used in emergencies such as anaphylaxis and shock, under medical supervision.
BC-Complex is a health supplement containing essential B-group vitamins. It helps in the management of vitamin B deficiencies and supports overall metabolism, energy production, nervous system health, liver function, and skin health. It is commonly prescribed in conditions such as weakness, fatigue, loss of appetite, anemia, and during recovery from illness.
Amikazal-500 is an injectable antibiotic containing amikacin, an aminoglycoside antibiotic effective against a wide range of gram-negative bacteria and some gram-positive organisms. It is used in the treatment of severe bacterial infections including respiratory tract infections, urinary tract infections, intra-abdominal infections, septicemia, skin and soft tissue infections, bone and joint infections, and hospital-acquired infections.
Z’Locks-CV is a pediatric dry syrup formulation containing amoxycillin ,clavulanic acid and lactic acid bacillus. This combination is prescribed for respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections caused by susceptible bacteria. The lactic acid bacillus supports intestinal health and helps reduce the risk of antibiotic-associated diarrhea, improving tolerance and compliance in children.
Z’Locks-DDS 100 mg is a probiotic formulation containing Saccharomyces boulardii, a beneficial yeast used in the prevention and treatment of diarrhea. It is effective in antibiotic-associated diarrhea, acute infectious diarrhea, traveler’s diarrhea, and diarrhea related to gastrointestinal disturbances. The DDS (Dual Drug System) presentation ensures stability and accurate dosing after reconstitution. It helps restore normal gut flora, reduces the severity and duration of diarrhea, and improves digestive health in both children and adults.
Z’Locks is a probiotic and prebiotic oral formulation designed to restore and maintain healthy intestinal flora. It is commonly prescribed in children and adults for the prevention and treatment of diarrhea, including antibiotic-associated diarrhea, infectious diarrhea, and diarrhea related to gastrointestinal disturbances. The probiotic strains help re-establish normal gut microflora, while prebiotics enhance their growth and activity.
Z’Furo-CV is a combination antibiotic formulation containing cefuroxime axetil, a second-generation cephalosporin, and clavulanic acid, a beta-lactamase inhibitor. This combination enhances the antibacterial spectrum of cefuroxime against resistant organisms. It is used in the treatment of bacterial infections including respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and certain gastrointestinal infections.
Z’Furo-125 is a pediatric dry syrup formulation containing cefuroxime axetil, a second-generation cephalosporin antibiotic. It is indicated for the treatment of respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and certain gastrointestinal infections caused by susceptible bacteria. The 125 mg strength corresponds to cefuroxime content per 5 ml of reconstituted suspension.
Zalmoxi-CV Duo 457 is a pediatric dry syrup oral suspension containing amoxycillin (400 mg) and clavulanic acid (57 mg) per 5 ml. This higher-strength “DUO” formulation provides a convenient dosing option for children, reducing the frequency of administration. It is indicated for the treatment of bacterial infections including respiratory tract infections, urinary tract infections, ENT infections, skin and soft tissue infections, and gastrointestinal infections.
Zalmoxi-CV is a combination antibiotic containing amoxycillin, a broad-spectrum penicillin, and clavulanic acid, a beta-lactamase inhibitor. This formulation is used in pediatric and adult patients for the treatment of bacterial infections such as respiratory tract infections, urinary tract infections, ENT infections, skin and soft tissue infections, and gastrointestinal infections.
Zalclav-CV LB is a pediatric dry syrup formulation that contains amoxycillin , clavulanic acid and lactic acid bacillus . This combination is used in children for the treatment of bacterial infections such as respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections. The lactic acid bacillus helps maintain gut flora and reduces the risk of antibiotic-associated diarrhea, improving tolerance and compliance in pediatric patients.
Zalclav-CV is a combination antibiotic containing amoxycillin, a broad-spectrum penicillin, and clavulanic acid, a beta-lactamase inhibitor. This formulation is used for the treatment of a wide range of bacterial infections including respiratory tract infections, urinary tract infections, ENT infections, skin and soft tissue infections, and gastrointestinal infections. Clavulanic acid protects amoxycillin from enzymatic degradation, thereby extending its antibacterial activity against resistant organisms.
Zalmoxi-DDS is a dry syrup oral suspension that contains amoxycillin, a broad-spectrum penicillin antibiotic, and clavulanic acid, a beta-lactamase inhibitor. This dual drug system (DDS) formulation enhances antibacterial activity by protecting amoxycillin from enzymatic degradation. It is prescribed in pediatric patients for respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections caused by susceptible bacteria. The DDS pack ensures stability and accurate dosing after reconstitution.
Zalmoxi-125 LB is a pediatric dry syrup formulation containing amoxycillin, a broad-spectrum penicillin antibiotic, along with lactic acid bacillus as a probiotic. It is used in the treatment of bacterial infections of the respiratory tract, ear, nose, throat, urinary tract, skin, and gastrointestinal system. The addition of lactic acid bacillus helps restore gut microflora, reducing the risk of antibiotic-associated diarrhea.
Zalmoxi-CV LB is a dry syrup oral suspension containing amoxycillin , clavulanic acid , and lactic acid bacillus . This combination is used for pediatric patients in the treatment of respiratory tract infections, urinary tract infections, skin infections, ENT infections, and gastrointestinal infections caused by susceptible bacteria. The lactic acid bacillus helps to maintain healthy gut flora and minimizes antibiotic-associated diarrhea.
Zinc Biotics is a nutritional supplement that combines zinc with probiotics. It is generally prescribed for children to help manage and prevent diarrhea, particularly acute and persistent diarrhea, by restoring gut flora balance. Zinc supports immunity and improves intestinal mucosal healing, while probiotics help restore healthy gut bacteria.
Tozocef-LB Banana is a dry syrup oral suspension containing cefixime, a third-generation cephalosporin antibiotic, and lactic acid bacillus as a probiotic. It is used in pediatric patients for the treatment of bacterial infections of the respiratory tract, urinary tract, ear, nose, throat, and gastrointestinal system. The lactic acid bacillus helps restore healthy intestinal flora and prevents antibiotic-associated diarrhea.
Tozocef-LB is a dry syrup oral suspension containing cefixime and lactic acid bacillus. It is indicated for the treatment of bacterial infections in children, including respiratory tract infections, urinary tract infections, ENT infections, and gastrointestinal infections. The lactic acid bacillus helps restore gut flora and reduces antibiotic-associated diarrhea. It comes in a mango flavour and is supplied as a combi pack with water for reconstitution, specifically for pediatric use.
Tozocef-LB Strawberry is a dry syrup formulation containing cefixime, a third-generation cephalosporin antibiotic, along with lactic acid bacillus as a probiotic. It is used for the treatment of bacterial infections of the respiratory tract, urinary tract, ear, nose, throat, and gastrointestinal system. The lactic acid bacillus helps to restore gut flora and reduce antibiotic-associated diarrhea.
Tozocef-LB (Pineapple flavour) is a dry syrup containing Cefixime (50 mg) with Lactic Acid Bacillus (60 million spores) per 30 ml pack (15 gm/30 ml). It is supplied as a combi pack with water for reconstitution. The syrup is specially formulated in pineapple flavour to improve palatability for children and is intended for pediatric use only. Cefixime provides antibacterial action, while Lactic Acid Bacillus supports gut health by maintaining normal intestinal flora.
Tozocef-LB is a dry syrup containing Cefixime (50 mg) with Lactic Acid Bacillus (60 million spores) per 30 ml pack (15 gm/30 ml). It is supplied as a combi pack with water for reconstitution. The syrup comes in orange flavour, making it more acceptable for children. It is intended for pediatric use only. Cefixime is a third-generation cephalosporin antibiotic, while Lactic Acid Bacillus helps restore gut flora and reduce antibiotic-associated diarrhea.
Pedline'Z-100 is a Linezolid Oral Suspension (100 mg/30 ml). Each pack contains 12 gm/30 ml of dry syrup, supplied in a 30 ml glass bottle with WFI (Water for Injection) for reconstitution. This variant comes in mango flavour, making it suitable for pediatric use only. Linezolid is an oxazolidinone-class antibiotic effective against resistant bacterial infections, including MRSA and VRE.
Pedlock-CV DDS is a dry syrup containing Cefpodoxime Proxetil and Potassium Clavulanate per 30 ml bottle . It is supplied in a glass bottle with WFI for reconstitution. This product is intended for pediatric use only and provides enhanced antibacterial activity due to the combination of cefpodoximewith clavulanate .
Pedlock 50 is a dry syrup containing Cefpodoxime Oral Suspension I.P. (15 gm/30 ml). It is supplied with water for reconstitution. This variant comes in strawberry flavour and is intended for pediatric use only. Cefpodoxime is a third-generation cephalosporin antibiotic effective against a wide range of bacterial infections.
Pedlock 50 is a dry syrup containing Cefpodoxime Oral Suspension I.P. (15 gm/30 ml). It is supplied with water for reconstitution. The syrup comes in pineapple flavour, making it more palatable for pediatric patients. It is intended for pediatric use only and is effective in treating a variety of bacterial infections.
